1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Carephar

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2006

Location

China

Primary Industry

Healthcare Specialists

About

Based in Jiangsu, China and established in 2006, Carephar is a medical company that focuses on developing cardiovascular medicines and providing services in terms of drug research, pharmaceutical production and promotion.
Current Investors
Kaitai Capital, Zheshang Venture Capital, Feima

Request a demo to show more

Primary Industry
Healthcare Specialists
Sub Industries
Cardiology, Pharmaceutical Research & Development
Website
www.carephar.com
Verticals
Manufacturing
Company Stage
Series F
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2014
1,540,164,047
-
76,183,416
4.9%
90,091,633
5.8%
92,928,519
6%
31 Dec 2015
1,306,813,388
(15.2%)
91,055,910
7%
108,180,719
8.3%
106,393,333
8.1%
31 Dec 2016
1,246,432,199
(4.6%)
117,377,234
9.4%
135,784,516
10.9%
125,315,631
10.1%
31 Dec 2017
31 Dec 2018
31 Dec 2019

Unlock the recent years of financials and more for Carephar.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.